Related Experiment Videos

Effects of carcinogenic agents upon different mechanisms for intragenic recombination in mammalian cells

T Helleday1, C Arnaudeau, D Jenssen

  • 1Department of Genetic and Cellular Toxicology, Wallenberg Laboratory, Stockholm University, Sweden. helleday@genetics.su.se

Carcinogenesis
|July 17, 1998
PubMed

Insights

Carcinogens can impact genetic recombination in mammalian cells, influencing cancer development. Different assay systems reveal that carcinogens affect homologous recombination more broadly than non-homologous recombination.

Area of Science:

  • Genetics
  • Toxicology
  • Cell Biology

Background:

  • Carcinogens are known to influence genetic recombination in mammalian cells, potentially affecting carcinogenesis.
  • Existing in vitro assay systems for screening carcinogens have shown variable results.
  • The differential response of these systems necessitates further investigation into carcinogen effects on recombination.

Purpose of the Study:

  • To investigate the phenomenon of differing carcinogen effects across various mammalian cell assay systems.
  • To compare the recombinogenic effects of specific chemical and physical agents on homologous versus non-homologous recombination pathways.

Main Methods:

  • Utilized two distinct in vitro assay procedures in mammalian cells.
  • Assayed spontaneous duplication mutants sensitive to either homologous or non-homologous recombination.
  • Tested four carcinogens: Aroclor 1221, benzene, methyl methanesulphonate (MMS), and thiourea, alongside gamma- and UV-irradiation.

Main Results:

  • Aroclor 1221, benzene, methyl methanesulphonate (MMS), and gamma- and UV-irradiation elevated homologous recombination frequencies.
  • Thiourea did not significantly affect homologous recombination.
  • Only UV-irradiation demonstrably increased non-homologous recombination rates.

Conclusions:

  • Mammalian cell recombination pathways and substrate characteristics influence responses to carcinogenic factors.
  • Assay procedures for detecting carcinogen recombinogenicity must account for distinct mammalian recombination mechanisms.
  • Understanding these differences is crucial for accurate carcinogen screening and risk assessment.

Related Concept Videos